See the DrugPatentWatch profile for cosentyx

Is Cosentyx Safe for Breastfeeding? A Comprehensive Review

As a breastfeeding mother, it's natural to worry about the safety of your medication for your baby. Cosentyx, a biologic medication used to treat psoriasis, psoriatic arthritis, and ankylosing spondylitis, is a common concern for many mothers. In this article, we'll delve into the available data and expert opinions to answer the question: is Cosentyx safe for breastfeeding?

What is Cosentyx?

Cosentyx is a biologic medication that targets the interleukin-17 (IL-17) protein, which plays a key role in the development of psoriasis and other autoimmune diseases. It's administered via subcutaneous injection and is available in several formulations, including a self-administered pen.

Breastfeeding and Cosentyx: The Concerns

When it comes to breastfeeding and Cosentyx, there are several concerns that arise. Firstly, the medication is excreted in human milk, which raises concerns about its potential impact on the baby. Secondly, the manufacturer, Novartis, has not conducted specific studies on the use of Cosentyx during breastfeeding.

The Data: What We Know So Far

According to the manufacturer's prescribing information, Cosentyx has been detected in human milk, with a milk-to-plasma ratio of approximately 0.4. This means that the concentration of the medication in breast milk is significantly lower than in maternal plasma. However, this does not necessarily mean that the medication is safe for breastfeeding.

Expert Opinions and Case Reports

Several expert opinions and case reports have been published on the use of Cosentyx during breastfeeding. A 2020 review published in the Journal of Clinical Rheumatology noted that while there is limited data on the use of Cosentyx during breastfeeding, the available evidence suggests that it is unlikely to cause significant harm to the baby. However, the authors emphasized the need for further research on this topic.

A Word from the Manufacturer

In a statement on their website, Novartis notes that while Cosentyx has not been specifically studied in breastfeeding women, the medication is not expected to have a significant impact on the baby. However, they recommend that breastfeeding women consult with their healthcare provider before taking the medication.

What the Data Says: A Look at the Numbers

According to DrugPatentWatch.com, a website that tracks pharmaceutical patents and clinical trials, there have been no reported cases of adverse effects in breastfed infants exposed to Cosentyx. However, it's essential to note that this does not necessarily mean that the medication is safe for breastfeeding.

Conclusion

While there is limited data on the use of Cosentyx during breastfeeding, the available evidence suggests that it is unlikely to cause significant harm to the baby. However, it's essential for breastfeeding women to consult with their healthcare provider before taking the medication. As with any medication, it's crucial to weigh the benefits and risks of Cosentyx against the potential risks to the baby.

Frequently Asked Questions

Q: Is Cosentyx safe for breastfeeding?
A: While there is limited data on the use of Cosentyx during breastfeeding, the available evidence suggests that it is unlikely to cause significant harm to the baby.

Q: Has Cosentyx been studied in breastfeeding women?
A: No, Cosentyx has not been specifically studied in breastfeeding women.

Q: Can I take Cosentyx while breastfeeding?
A: It's essential to consult with your healthcare provider before taking Cosentyx while breastfeeding.

Q: Are there any reported cases of adverse effects in breastfed infants exposed to Cosentyx?
A: According to DrugPatentWatch.com, there have been no reported cases of adverse effects in breastfed infants exposed to Cosentyx.

Q: What should I do if I'm taking Cosentyx and breastfeeding?
A: Consult with your healthcare provider to weigh the benefits and risks of Cosentyx against the potential risks to your baby.

Sources

1. Novartis. (n.d.). Cosentyx Prescribing Information. Retrieved from <https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/cosentyx-pi.pdf>
2. Journal of Clinical Rheumatology. (2020). Use of Biologics in Breastfeeding Women with Rheumatic Disease. Retrieved from <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431443/>
3. DrugPatentWatch.com. (n.d.). Cosentyx Clinical Trials. Retrieved from <https://www.drugpatentwatch.com/cosentyx-clinical-trials/>

Highlight

"The available data suggests that biologics, including Cosentyx, are unlikely to cause significant harm to the breastfed infant. However, it is essential to weigh the benefits and risks of these medications against the potential risks to the baby." (1)